Hygene Biosciences Private Limited
About Hygene Biosciences Private Limited
Data last updated:
Hygene Biosciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 03 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51397TN2013PTC092823. Its GSTIN is 33AADCH2630R1ZG (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandramohandas Ayyappan and Natarajan Krishnamurthy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F3 Raaji Flats No.6/2&3 South Lock Street Kottur, Chennai, Tamil Nadu, India – 600096.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.72 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹7.54 Lakh (net margin 2%) and EBITDA of ₹10.6 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 27% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hygene Biosciences Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered AddressF3 Raaji Flats No.6/2&3 South Lock Street Kottur, Chennai, Tamil Nadu, India – 600096
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Hygene Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hygene Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hygene Biosciences Private Limited, buy the company report.
Financials of Hygene Biosciences Private Limited
FY 2025 filings availableHygene Biosciences Private Limited reported revenue of ₹3.72 Cr (up 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 13% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hygene Biosciences Private Limited, buy the company report.
Board of directors of Hygene Biosciences Private Limited
Hygene Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandramohandas Ayyappan Also directs: Siscon Biosolutions Private Limited | Director | 03 Sep 2013 | 13 Years 2 Months | Current |
| Natarajan Krishnamurthy Also directs: Siscon Biosolutions Private Limited | Director | 03 Sep 2013 | 13 Years 2 Months | Current |
Peer comparison
Hygene Biosciences Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Biosciences, Chemical Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ahir Fuels Private Limited | ₹3.76 Cr (FY 2025) | -11.0% | Kachchh, Gujarat, India | |||
| Green Shakti Energies Private Limited | ₹3.73 Cr (FY 2025) | 0.0% | Bhilai, Chhattisgarh, India | |||
| Jewel City Exports Private Limited | ₹3.72 Cr (FY 2022) | Surat, Gujarat, India | ||||
| Hygene Biosciences Private Limitedthis company | ₹3.72 Cr (FY 2024) | ₹7.54 Lakh | 2% | 13.0% | 10 | Chennai, Tamil Nadu, India |
| Rex Genia Life Sciences Private Limited | ₹3.71 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Hygene Biosciences Private Limited, buy the company report.
Auditor
Hygene Biosciences Private Limited is audited by A.Kaliannan & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.Kaliannan & Associates | FY 2017 | 011675S |
Shareholding
The shareholding of Hygene Biosciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Hygene Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hygene Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hygene Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hygene Biosciences Private Limited has a workforce of 10 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 10 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Hygene Biosciences Private Limited, buy the company report.
GST
Hygene Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCH2630R1ZG | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hygene Biosciences Private Limited, buy the company report.
Recent activity
Hygene Biosciences Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Chandramohandas Ayyappan was appointed as Director on 03 Sep 2013.
Frequently asked questions
Hygene Biosciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in other wholesale, within the trading industry. It was incorporated on 03 September 2013 (13+ years old) and is registered under CIN U51397TN2013PTC092823.
Hygene Biosciences has 2 current directors:
- Chandramohandas Ayyappan - Director
- Natarajan Krishnamurthy - Director
The latest financial statements of Hygene Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hygene Biosciences is 33AADCH2630R1ZG, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Hygene Biosciences is U51397TN2013PTC092823. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hygene Biosciences was incorporated on 03 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Hygene Biosciences by revenue are Ahir Fuels Private Limited, Green Shakti Energies Private Limited, Jewel City Exports Private Limited, Rex Genia Life Sciences Private Limited, all in the Chemicals industry (Biosciences, Chemical Retail and Distribution), with the same principal business activity (wholesale trading).
Chandramohandas Ayyappan was appointed as Director on 03 Sep 2013. Natarajan Krishnamurthy was appointed as Director on 03 Sep 2013.
The registered office of Hygene Biosciences is at F3 Raaji Flats No.62&3 South Lock Street Kottur, Chennai, Tamil Nadu, India – 600096.
Hygene Biosciences operates in the trading industry, in the other wholesale segment.
The compliance status of Hygene Biosciences is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
